Search

Your search keyword '"Suga, Sachie"' showing total 35 results
Start Over Author "Suga, Sachie"
35 results on '"Suga, Sachie"'

1. Survival and unique clinical practices of extremely preterm infants born at 22–23 weeks’ gestation in Japan: a national survey

Author

Isayama, Tetsuya, primary, Miyakoshi, Kei, additional, Namba, Fumihiko, additional, Hida, Mariko, additional, Morioka, Ichiro, additional, Ishii, Keisuke, additional, Miyashita, Susumu, additional, Uehara, Shuichiro, additional, Kinoshita, Yoshiaki, additional, Suga, Sachie, additional, Nakahata, Katsutoshi, additional, Uchiyama, Atsushi, additional, and Otsuki, Katsufumi, additional

Published
2024
Full Text
View/download PDF

6. Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)

Author

Maki, Shintaro, primary, Tanaka, Hiroaki, additional, Takakura, Sho, additional, Nii, Masafumi, additional, Tanaka, Kayo, additional, Ogura, Toru, additional, Kotera, Mayumi, additional, Nishimura, Yuki, additional, Tamaru, Satoshi, additional, Ushida, Takafumi, additional, Tanaka, Yasuhiro, additional, Kikuchi, Norihiko, additional, Kinjo, Tadatsugu, additional, Kawamura, Hiroshi, additional, Takano, Mayumi, additional, Nakamura, Koji, additional, Suga, Sachie, additional, Kasai, Michi, additional, Yasui, Osamu, additional, Nagao, Kenji, additional, Maegawa, Yuka, additional, Kotani, Tomomi, additional, Endo, Masayuki, additional, Yasuhi, Ichiro, additional, Aoki, Shigeru, additional, Aoki, Yoichi, additional, Yoshida, Yoshio, additional, Nakata, Masahiko, additional, Sekizawa, Akihiko, additional, and Ikeda, Tomoaki, additional

Published
2022
Full Text
View/download PDF

9. Etiology of Fetal Growth Restriction.: FC 1.02

Author

Yasuhi, Ichiro, Suga, Sachie, Kubo, Norio, Nomiyama, Makoto, Kawakami, Kosuke, Okura, Naofumi, Hayashi, Koichi, Mizunoe, Tomoya, Kodama, Takashi, Maekawa, Yuka, Kusaka, Hideto, Maeda, Makoto, Egawa, Haruto, Tada, Katsuhiko, and Maeda, Kazuhisa

Published
2015

12. Vaginal Ureaplasma urealyticum or Mycoplasma hominis and preterm delivery in women with threatened preterm labor.

Author

Miyoshi, Yasuhiro, Suga, Sachie, Sugimi, So, Kurata, Nao, Yamashita, Hiroshi, and Yasuhi, Ichiro

Subjects
*PREMATURE labor, *AMNIOTIC liquid, *UREAPLASMA, *MYCOPLASMA, *UTERINE contraction
Abstract

Amniotic fluid infection with Ureaplasma urealyticum or Mycoplasma hominis can cause chorioamnionitis and preterm birth. The aim of this study was to examine whether vaginal Ureaplasma urealyticum/Mycoplasma hominis colonization is predictive of preterm delivery in patients exhibiting signs of threatened preterm birth or those with asymptomatic short cervix. The present retrospective study, which was performed in a perinatal tertiary center, included patients carrying a singleton pregnancy who were referred to the emergency Ob/Gyn unit because of regular preterm uterine contractions and/or short cervical length (<20 mm) at 22–33 weeks of gestation, and in whom a vaginal U. urealyticum/M. hominis examination (Urea-arginine LYO-2, BioMerieux®) was performed. Univariate and multivariate analyses were performed to assess the association between vaginal U. urealyticum or M. hominis and chorioamnionitis or preterm delivery. The median gestational age of the 94 enrolled patients was 29.9 weeks, and 54 (57%) of the patients were vaginal U. urealyticum/M. hominis-positive. The preterm delivery rate in the positive group was higher than in the negative group (53 versus 25%; p =.007). Vaginal U. urealyticum/M. hominis positivity was found to be an independent risk factor for preterm birth at <37 weeks of gestation (adjusted odds ratio = 4.0, 95% confidence interval, 1.1–15.3) in a multivariate analysis adjusted for age, history of preterm delivery and conization, gestational age, cervical length, presence of vaginal bleeding, vaginal fetal fibronectin and serum C-reactive protein at test. U. urealyticum/M. hominis positivity was not associated with delivery at <34 weeks or chorioamnionitis. A positive vaginal U. urealyticum/M. hominis culture is an independent predictive factor for preterm birth in patients with symptomatic threatened preterm labor and/or short cervix. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

18. Comparison of the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without bolus injection during caesarean section.

Author

Miyoshi, Yasuhiro, Kaneko, Shohei, Suga, Sachie, Koga, Megumi, Sugimi, So, Yamashita, Hiroshi, Yamaguchi, Michiko, and Yasuhi, Ichiro

Subjects
INTRAVENOUS therapy, CESAREAN section, BOLUS drug administration, INJECTIONS, OXYTOCIN
Abstract

The aim of this study was to compare the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without a bolus injection during a caesarean section. Women with singleton pregnancies who underwent caesarean sections under spinal anaesthesia were included. Oxytocin was administered by an iv bolus injection (5 U) followed by an intravenous infusion (10 U of oxytocin in 500 mL normal saline); this was switched to just an intravenous infusion. The amount of blood loss did not differ between the groups. In a multivariate analysis, the adjusted odds ratios for the risk of hypotension (≥20% reduction of systolic BP) and tachycardia (heart rate ≥100 bpm) were 4.5 (95% confidence interval [CI], 1.6–12.5) and 3.7 (95%CI 1.9–7.2) in the iv bolus group, respectively, compared with the just the infusion group. The oxytocin administration by iv bolus injection did not decrease blood loss and increased the rate of hemodynamic side effects. What is already known on this subject? Oxytocin is used as the first-line uterotonic treatment to prevent a postpartum haemorrhage in women undergoing Caesarean Sections. Oxytocin is known to relax vascular smooth muscle, which can cause hypotension and tachycardia. The protocols for administering oxytocin during CS vary by institution. What do the results of this study add? Combined treatment with oxytocin by iv bolus injection (5 U) followed by iv infusion (10 U of oxytocin in 500 mL normal saline) during CS increased the risk of developing adverse hemodynamic side effects, including hypotension, tachycardia, and the need for vasopressors, without any benefit in the control of intraoperative blood loss in comparison to iv infusion alone. What are the implications of these findings for clinical practice and/or further research? We should abandon the iv bolus injection of oxytocin during CS, especially for women undergoing an elective CS who are not in labour. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

30. 262: Risk factors associated with postpartum impaired glucose tolerance at the first postpartum screening in women with gestational diabetes

Author

Kugishima, Yukari, primary, Yasuhi, Ichiro, additional, Yamashita, Hiroshi, additional, Fukuda, Masashi, additional, Watanabe, Takeshi, additional, Mizutani, Yoshinori, additional, Kuzume, Akiko, additional, Hashimoto, Takashi, additional, Sugimi, So, additional, Umezaki, Yasushi, additional, Suga, Sachie, additional, and Kusuda, Nobuko, additional

Published
2013
Full Text
View/download PDF

31. 261: Cord serum C peptide levels in large-for-gestational age infants in diabetic and non-diabetic mothers

Author

Yasuhi, Ichiro, primary, Yamashita, Hiroshi, additional, Fukuda, Masashi, additional, Kugishima, Yukari, additional, Watanabe, Takeshi, additional, Mizutani, Yoshinori, additional, Kuzume, Akiko, additional, Hashimoto, Takashi, additional, Sugimi, So, additional, Umezaki, Yasushi, additional, Suga, Sachie, additional, and Kusuda, Nobuko, additional

Published
2013
Full Text
View/download PDF

32. Risk factors associated with respiratory disorders in late preterm infants.

Author

Suga, Sachie, Yasuhi, Ichiro, Aoki, Mikihiro, Nomiyama, Makoto, Kubo, Norio, Kawakami, Kosuke, Okura, Naohumi, Okazaki, Kaoru, Ota, Akira, and Kawada, Kou

Subjects
*PREMATURE labor, *PREMATURE infants, *CONGENITAL disorders, *RESPIRATORY therapy for newborn infants, *ARTIFICIAL respiration, *COMPARATIVE studies, *PREMATURE infant diseases, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESPIRATORY diseases, *EVALUATION research, *RETROSPECTIVE studies
Abstract

Objective: Late preterm infants are still high risk for respiratory problems. The aim of this study was to identify risk factors associated with respiratory problems in Japanese late preterm infants.Methods: In this retrospective multicenter study, we included singleton late preterm deliveries at 34+(0/7)-36+(6/7) weeks of gestation. We excluded cases with congenital anomalies. We defined neonatal respiratory disorders (NRD) as the combination of the need for mechanical ventilation or the use of nasal continuous positive airway pressure. We examined the perinatal risk factors associated with NRD.Results: We included 683 late preterm infants. We found that 13.7%, 6.8% and 2.6% of the infants with NRD were born at 34, 35 and 36 weeks of gestation, respectively. In a multivariate logistic regression analysis adjusting for confounders, the gestational age (GA) at birth (adjusted odds ratio 0.40 per week [95% confidence interval, 0.25-0.61]), cesarean birth (4.18 [2.11-8.84]), and a low Apgar score (33.3 [9.93-121.3]) were independent risk factors associated with NRD.Conclusions: An earlier GA, cesarean delivery, and a low Apgar score are independent risk factors associated with NRD in singleton late preterm infants. Patients with late preterm deliveries exhibiting these risk factors should be managed in the intensive delivery setting. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

34. 203: Indices of insulin resistance and β-cell function in women with gestational diabetes, pregnancy-induced hypertension, and preterm delivery

Author

Yamashita, Hiroshi, primary, Fukuda, Masahi, additional, Kugishima, Yukari, additional, Yamauchi, Yuki, additional, Kuzume, Akiko, additional, Hashimoto, Takashi, additional, Sugimi, So, additional, Yatsunami, Naoko, additional, Suga, Sachie, additional, Kusuda, Nobuko, additional, and Yasuhi, Ichiro, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results